Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene expression and molecular pathway analyses differentiate immunotherapy-induced myositis from spontaneous dermatomyositis. | Sci Rep | 2025 | 40759686 | PubTator, text mining | PubMed |
| Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma. | Blood | 2025 | 40749164 | PubTator, text mining | PubMed |
| T cell Activation Marker HLA-DR Reflects Tacrolimus-Associated Immunosuppressive Burden and BK Viremia Risk After Kidney Transplantation - An Observational Cohort Study. | Transpl Int | 2025 | 40747140 | PubTator, text mining | PubMed |
| Phenotypic alterations in immune cells and their association with toxicities in postoperative endometrial cancer patients undergoing brachytherapy. | Front Oncol | 2025 | 40740877 | PubTator, text mining | PubMed |
| Identification the correlation between hip and knee osteoarthritis and their causal relationship with immune traits. | BMC Musculoskelet Disord | 2025 | 40713593 | PubTator, text mining | PubMed |
| Influenza A virus disruption of dendritic cell-natural killer cell crosstalk impacts activation of naïve helper and cytotoxic T cell subsets. | Immunohorizons | 2025 | 40682362 | PubTator, text mining | PubMed |
| Clinical trial assessing the safety and efficacy of human bone marrow-derived allogeneic mesenchymal stem cell therapy for chronic active antibody-mediated rejection in kidney transplant recipients. | Cytotherapy | 2025 | 40663031 | PubTator, text mining | PubMed |
| Serotype-specific host proteome remodeling in human foreskin fibroblasts during lytic HSV-1 and HSV-2 infection. | Virol J | 2025 | 40660299 | PubTator, text mining | PubMed |
| Novel pathogenic variants in CTLA4 and LRBA immune dysregulation: Reduced CTLA-4 expression with normal expression of co-stimulatory surface molecules. | Clin Immunol | 2025 | 40651735 | PubTator, text mining | PubMed |
| Activation of sclerostin inhibits Isg20-Mediated aerobic glycolysis ameliorating renal Fibrosis: the renoprotective mechanism of hederagenin in CKD. | Redox Biol | 2025 | 40644925 | PubTator, text mining | PubMed |
| Throwing the microbiome out with the bathwater. | Blood Adv | 2025 | 40627346 | PubTator, text mining | PubMed |
| Targeting interferon-stimulated gene of 20 kDa protein (Isg20) inhibits ribosome biogenesis to ameliorate the progression of renal fibrosis. | PLoS One | 2025 | 40622935 | PubTator, text mining | PubMed |
| Spectral Flow Cytometry: The Current State and Future of the Technology. | Int J Mol Sci | 2025 | 40565376 | PubTator, text mining | PubMed |
| A Machine Learning-Based Diagnostic Nomogram for Moyamoya Disease: The Validation of Hypoxia-Immune Gene Signatures. | Bioengineering (Basel) | 2025 | 40564394 | PubTator, text mining | PubMed |
| Construction of an immune-related prognostic model and functional analysis of CEBPB in uveal melanoma: A STROBE-compliant observational study. | Medicine (Baltimore) | 2025 | 40550050 | PubTator, text mining | PubMed |
| Increase of CD4+CD25+FoxP3+Regulatory T Cells in Myeloma. | Clin Lab | 2025 | 40497604 | PubTator, text mining | PubMed |
| Mapping the role of cytokine signaling at single-cell and structural resolution in uveal melanoma. | Genes Immun | 2025 | 40490526 | PubTator, text mining | PubMed |
| Structural features, transcriptional profiles, and potential roles in antiviral immunity of interferon-stimulated 20-kDa exonuclease (ISG20) in red-spotted grouper (Epinephelus akaara). | Fish Shellfish Immunol | 2025 | 40484065 | PubTator, text mining | PubMed |
| Transcriptomic insights into the mechanism of action of telomere-related biomarkers in rheumatoid arthritis. | Front Immunol | 2025 | 40475761 | PubTator, text mining | PubMed |
| Peripheral memory B cell population maintenance and long-term survival after perioperative chemoimmunotherapy in NSCLC (NADIM trial). | Oncoimmunology | 2025 | 40468805 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=7